儿科腹腔疾病的医疗保健资源利用率和成本:使用德国保险数据的病例控制研究
Sibylle Koletzko1,2, Svitlana Schnaidt3, Leonarda Serdani-Neuhaus4
1Department of Pediatrics, Dr. von Hauner Children's Hospital, LMU University Hospital Munich, Munich, Germany.
Journal of pediatric gastroenterology and nutrition
|October 17, 2025
概括
新诊断的儿科乳病 (CeD) 在德国显著增加了医疗保健资源利用率和成本. 这项研究突显了CeD对年轻患者和医疗保健系统的巨大负担.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 卫生经济学 卫生经济学
- 公共卫生 公共卫生
背景情况:
- 乳病 (CeD) 是一种慢性免疫疾病,在德国对其儿科负担的数据有限.
- 了解医疗保健资源利用率 (HCRU) 和成本对于有效管理至关重要.
研究的目的:
- 评估与德国新诊断的儿科CeD相关的HCRU和医疗保健成本.
- 将CeD儿童的资源使用和支出与匹配的对照进行比较.
主要方法:
- 使用德国法定医疗保险索赔数据 (2014-2021) 进行了回顾性病例控制研究.
- 将HCRU (住院,门诊接触,处方) 和CeD患者 (<6岁和6-11岁) 的成本与匹配的非CeD对照 (1:5比率) 进行比较.
- 分析涵盖了诊断期和诊断后的两年.
主要成果:
- 鉴定了410个CeD病例,发病率为每10万人中32.5-34.1人.
- CeD患者的HCRU显着更高,包括更多的住院治疗,门诊接触和处方.
- 对于CeD患者来说,医疗保健总费用显著上升 (年轻和老年人群的平均差异分别为1677欧元和1343欧元).
结论:
- 儿童腹病对德国的患者和医疗保健系统都造成了重大负担.
- 调查结果强调需要有针对性的干预措施和改善儿童CeD的管理策略.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
241
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
241
Pharmacokinetics in Pediatric Patients: Drug Metabolism
191
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
191
Pharmacokinetics in Pediatric Patients: Drug Distribution
251
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
635
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
635
Health Information Technology and Healthcare Information System
3.3K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion
209
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
209


